ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 5.93% of EFTR shares are held by financial institutions. BLACKSTONE INC. is the top corporate investor, holding 52.34K shares valued at $753.22K. A 2.39% stake in eFFECTOR Therapeutics, Inc. is owned by the company. JPMORGAN CHASE & CO owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the EFTR insiders holding of 2.91% of the stake in company, SR ONE CAPITAL MANAGEMENT, LLC, 10 percent owner, holds the largest shares of 1.82M. WORLAND STEPHEN T, President and Chief Executive, is the second largest EFTR insider with ownership of 214.98K shares. ROOT JONATHAN D, , stands third with possession of 127.57K shares of that stake.